Literature DB >> 25892109

The Activation Mechanism of 2'-5'-Oligoadenylate Synthetase Gives New Insights Into OAS/cGAS Triggers of Innate Immunity.

Jan Lohöfener1, Nicola Steinke1, Penelope Kay-Fedorov2, Petra Baruch3, Alexey Nikulin4, Svetlana Tishchenko4, Dietmar J Manstein5, Roman Fedorov6.   

Abstract

2'-5'-Oligoadenylate synthetases (OASs) produce the second messenger 2'-5'-oligoadenylate, which activates RNase L to induce an intrinsic antiviral state. We report on the crystal structures of catalytic intermediates of OAS1 including the OAS1·dsRNA complex without substrates, with a donor substrate, and with both donor and acceptor substrates. Combined with kinetic studies of point mutants and the previously published structure of the apo form of OAS1, the new data suggest a sequential mechanism of OAS activation and show the individual roles of each component. They reveal a dsRNA-mediated push-pull effect responsible for large conformational changes in OAS1, the catalytic role of the active site Mg(2+), and the structural basis for the 2'-specificity of product formation. Our data reveal similarities and differences in the activation mechanisms of members of the OAS/cyclic GMP-AMP synthase family of innate immune sensors. In particular, they show how helix 3103-α5 blocks the synthesis of cyclic dinucleotides by OAS1.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25892109     DOI: 10.1016/j.str.2015.03.012

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  24 in total

1.  Functional evolution of the OAS1 viral sensor: Insights from old world primates.

Authors:  Ian Fish; Stéphane Boissinot
Journal:  Infect Genet Evol       Date:  2016-07-05       Impact factor: 3.342

2.  ELTA: Enzymatic Labeling of Terminal ADP-Ribose.

Authors:  Yoshinari Ando; Elad Elkayam; Robert Lyle McPherson; Morgan Dasovich; Shang-Jung Cheng; Jim Voorneveld; Dmitri V Filippov; Shao-En Ong; Leemor Joshua-Tor; Anthony K L Leung
Journal:  Mol Cell       Date:  2019-01-31       Impact factor: 17.970

3.  Recurrent Loss-of-Function Mutations Reveal Costs to OAS1 Antiviral Activity in Primates.

Authors:  Clayton M Carey; Apurva A Govande; Juliane M Cooper; Melissa K Hartley; Philip J Kranzusch; Nels C Elde
Journal:  Cell Host Microbe       Date:  2019-01-31       Impact factor: 21.023

4.  HORMA Domain Proteins and a Trip13-like ATPase Regulate Bacterial cGAS-like Enzymes to Mediate Bacteriophage Immunity.

Authors:  Qiaozhen Ye; Rebecca K Lau; Ian T Mathews; Erica A Birkholz; Jeramie D Watrous; Camillia S Azimi; Joe Pogliano; Mohit Jain; Kevin D Corbett
Journal:  Mol Cell       Date:  2020-01-10       Impact factor: 17.970

Review 5.  RNA regulation of the antiviral protein 2'-5'-oligoadenylate synthetase.

Authors:  Samantha L Schwartz; Graeme L Conn
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-04-15       Impact factor: 9.957

6.  Prevalence of the SNP rs10774671 of the OAS1 gene in Mexico as a possible predisposing factor for RNA virus disease.

Authors:  María Teresa Sánchez-González; Oscar Cienfuegos-Jiménez; Salomón Álvarez-Cuevas; Antonio Ali Pérez-Maya; Gissela Borrego-Soto; Iván Alberto Marino-Martínez
Journal:  Int J Mol Epidemiol Genet       Date:  2021-06-15

7.  Structural and biochemical characterization of the cell fate determining nucleotidyltransferase fold protein MAB21L1.

Authors:  Carina C de Oliveira Mann; Reiner Kiefersauer; Gregor Witte; Karl-Peter Hopfner
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

8.  Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency.

Authors:  Thomas Magg; Tsubasa Okano; Lars M Koenig; Daniel F R Boehmer; Samantha L Schwartz; Kento Inoue; Jennifer Heimall; Francesco Licciardi; Julia Ley-Zaporozhan; Ronald M Ferdman; Andrés Caballero-Oteyza; Esther N Park; Brenda M Calderon; Debayan Dey; Hirokazu Kanegane; Kazutoshi Cho; Davide Montin; Karl Reiter; Matthias Griese; Michael H Albert; Meino Rohlfs; Paul Gray; Christoph Walz; Graeme L Conn; Kathleen E Sullivan; Christoph Klein; Tomohiro Morio; Fabian Hauck
Journal:  Sci Immunol       Date:  2021-06-18

9.  FAM46 proteins are novel eukaryotic non-canonical poly(A) polymerases.

Authors:  Krzysztof Kuchta; Anna Muszewska; Lukasz Knizewski; Kamil Steczkiewicz; Lucjan S Wyrwicz; Krzysztof Pawlowski; Leszek Rychlewski; Krzysztof Ginalski
Journal:  Nucleic Acids Res       Date:  2016-04-07       Impact factor: 16.971

10.  Endomembrane targeting of human OAS1 p46 augments antiviral activity.

Authors:  Frank W Soveg; Johannes Schwerk; Nandan S Gokhale; Karen Cerosaletti; Julian R Smith; Erola Pairo-Castineira; Alison M Kell; Adriana Forero; Shivam A Zaver; Katharina Esser-Nobis; Justin A Roby; Tien-Ying Hsiang; Snehal Ozarkar; Jonathan M Clingan; Eileen T McAnarney; Amy El Stone; Uma Malhotra; Cate Speake; Joseph Perez; Chiraag Balu; Eric J Allenspach; Jennifer L Hyde; Vineet D Menachery; Saumendra N Sarkar; Joshua J Woodward; Daniel B Stetson; John Kenneth Baillie; Jane H Buckner; Michael Gale; Ram Savan
Journal:  Elife       Date:  2021-08-03       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.